A retrospective study analysing renal allograft outcomes in HCV NAT negative patients who received kidney transplant from HCV Ab+/NAT with hepatitis C antibody seroconversion and without seroconversion
Latest Information Update: 13 Jul 2020
At a glance
- Drugs Antithymocyte globulin (Primary) ; Mycophenolate (Primary) ; Prednisone (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 13 Jul 2020 New trial record
- 03 Jun 2020 Results presented at the 2020 American Transplant Congress